Clinical Trials

NCT Number: NCT05805371 Phase: PHASE1 Trial Summary: This phase Ib trial tests the safety, side effects, and best dose of autologous anti-prostate stem cell antigen (PSCA)-chimeric antigen receptor (CAR)-4-1BB/TCRzeta-CD19t-expressing T-lymphocytes (PSC – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): City of Hope Medical Center Acronym:

NCT Number: NCT02558946 Phase: NA Trial Summary: The purpose of this study is to determine if pelvic floor muscle training with a physical therapist before and after surgery will improve health-related quality of life following robot-assisted radica – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Indiana University Acronym:

NCT Number: NCT04081636 Phase: NA Trial Summary: This study evaluates the difference between 2 prostate biopsy methods, transrectal (through the rectal wall) and transperineal (through the skin) needle biopsy. Men who are in need of prostate biopsy – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Albany Medical College Acronym: ProBE-PC

NCT Number: NCT02871726 Phase: NA Trial Summary: Prostate cancer (PCa) is the most common non-dermatologic malignancy in U.S. men. Transrectal ultrasound (TRUS)-guided prostate biopsy is a commonly used diagnostic procedure for men with an elevated – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Johns Hopkins University Acronym:

NCT Number: NCT04565457 Phase: NA Trial Summary: This is Pilot study that investigates the CBCT(Cone beam computed tomography) image quality improvement provided by the 2D antiscatter grid technology. The primary objective is to assess the improveme – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): University of Colorado, Denver Acronym:

NCT Number: NCT04573231 Phase: PHASE2 Trial Summary: The purpose of this research is to determine the expression of prostate specific membrane antigen (PSMA) in human epidermal growth factor receptor 2 (HER2)-negative, androgen receptor (AR)-positive me – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): University of Wisconsin, Madison Acronym:

NCT Number: NCT04599218 Phase: NA Trial Summary: This research study is designed to determine if targeted Magnetic Resonance Imaging (MRI) Ultrasound (US) fusion biopsy is better than the standard of care ultrasound guided biopsy alone in diagnosing – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Ardeshir Rastinehad Acronym:

NCT Number: NCT05515978 Phase: Early Phase 1 Trial Summary: Metformin is used widely in the treatment of type 2 diabetes. It has off-label indications for use in the prevention of diabetes and in hyperinsulinar obesity. In medical practices, the implementation – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): University of Colorado, Denver Acronym:

NCT Number: NCT05519878 Phase: Not Applicable Trial Summary: This clinical trial evaluates light therapy and occupational therapy in improving cancer related fatigue (CRF) patients with genitourinary cancers. Light therapy is a non-pharmacological and evidence- – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): City of Hope Medical Center|National Cancer Institute (NCI) Acronym:

NCT Number: NCT05683691 Phase: Not Applicable Trial Summary: The purpose of this study is to evaluate the safety and efficacy of the Vanquish Water Vapor Ablation Device (“Vanquish”) in treating subjects with Gleason Grade Group 2 (GGG2) localized intermediate- – clinicaltrials.gov for more information and locations Clinicaltrials.gov Trial Sponsor(s): Francis Medical Inc. Acronym: VAPOR 2